Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy

G. Bacci, S. Ferrari, A. Longhi, S. Perin, C. Forni, N. Fabbri, N. Salduca, M. Versari, K. V J Smith

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

570 patients with osteosarcoma of the extremities were treated with five different protocols of neoadjuvant chemotherapy at Rizzoli Institute between 1983 and 1995. Surgery consisted of limb salvage in 83% rotation plasty in 5% and amputation in 12%. The 5-year event-free survival (EFS) was 60% which varied according to the protocol followed, ranging from 47.6% to 66.4%. 234 patients relapsed. The pattern of relapse was analysed. The mean relapse time was 23.8 months (range: 2-96). The first site of systemic relapse was the lung in 88% (32% of these had less than three pulmonary metastases and 68% three or more), bone in 9%, lung and bone in 2% and other sites in 3%. The relapse time and the number of pulmonary metastases were strictly correlated with the efficacy of the protocol of chemotherapy used. Patients treated with the three protocols that gave a 5-year EFS of more than 60% relapsed later and had fewer pulmonary lesions than patients treated with the two protocols that gave a 5-year EFS of 47.6% and 52.5%. The rate of local recurrence was relatively low (6%). This was not correlated with the protocol or the type of surgery used: limb salvage (6.4%), rotation plasty or amputation (4.1%). However, the rate of local recurrence was very high (21.9%) in the few patients (7%) that had less than wide surgical margins. We conclude that for patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy: (a) the pattern of systemic relapse changes according to the efficacy of the protocol of chemotherapy used. This should be always considered when evaluating the preliminary results of new studies as well as in defining the time of follow-up; (b) limb salvage procedures are safe and do not jeopardise the outcome of the patient, provided that wide surgical margins are achieved.

Original languageEnglish
Pages (from-to)32-38
Number of pages7
JournalEuropean Journal of Cancer
Volume37
Issue number1
DOIs
Publication statusPublished - 2001

Fingerprint

Osteosarcoma
Extremities
Recurrence
Drug Therapy
Limb Salvage
Lung
Disease-Free Survival
Amputation
Neoplasm Metastasis
Bone and Bones

Keywords

  • Chemotherapy
  • Osteosarcoma
  • Systemic relapse

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. / Bacci, G.; Ferrari, S.; Longhi, A.; Perin, S.; Forni, C.; Fabbri, N.; Salduca, N.; Versari, M.; Smith, K. V J.

In: European Journal of Cancer, Vol. 37, No. 1, 2001, p. 32-38.

Research output: Contribution to journalArticle

Bacci, G. ; Ferrari, S. ; Longhi, A. ; Perin, S. ; Forni, C. ; Fabbri, N. ; Salduca, N. ; Versari, M. ; Smith, K. V J. / Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. In: European Journal of Cancer. 2001 ; Vol. 37, No. 1. pp. 32-38.
@article{f823297b8fa949adb616ba7fe718a5b7,
title = "Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy",
abstract = "570 patients with osteosarcoma of the extremities were treated with five different protocols of neoadjuvant chemotherapy at Rizzoli Institute between 1983 and 1995. Surgery consisted of limb salvage in 83{\%} rotation plasty in 5{\%} and amputation in 12{\%}. The 5-year event-free survival (EFS) was 60{\%} which varied according to the protocol followed, ranging from 47.6{\%} to 66.4{\%}. 234 patients relapsed. The pattern of relapse was analysed. The mean relapse time was 23.8 months (range: 2-96). The first site of systemic relapse was the lung in 88{\%} (32{\%} of these had less than three pulmonary metastases and 68{\%} three or more), bone in 9{\%}, lung and bone in 2{\%} and other sites in 3{\%}. The relapse time and the number of pulmonary metastases were strictly correlated with the efficacy of the protocol of chemotherapy used. Patients treated with the three protocols that gave a 5-year EFS of more than 60{\%} relapsed later and had fewer pulmonary lesions than patients treated with the two protocols that gave a 5-year EFS of 47.6{\%} and 52.5{\%}. The rate of local recurrence was relatively low (6{\%}). This was not correlated with the protocol or the type of surgery used: limb salvage (6.4{\%}), rotation plasty or amputation (4.1{\%}). However, the rate of local recurrence was very high (21.9{\%}) in the few patients (7{\%}) that had less than wide surgical margins. We conclude that for patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy: (a) the pattern of systemic relapse changes according to the efficacy of the protocol of chemotherapy used. This should be always considered when evaluating the preliminary results of new studies as well as in defining the time of follow-up; (b) limb salvage procedures are safe and do not jeopardise the outcome of the patient, provided that wide surgical margins are achieved.",
keywords = "Chemotherapy, Osteosarcoma, Systemic relapse",
author = "G. Bacci and S. Ferrari and A. Longhi and S. Perin and C. Forni and N. Fabbri and N. Salduca and M. Versari and Smith, {K. V J}",
year = "2001",
doi = "10.1016/S0959-8049(00)00361-0",
language = "English",
volume = "37",
pages = "32--38",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "1",

}

TY - JOUR

T1 - Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy

AU - Bacci, G.

AU - Ferrari, S.

AU - Longhi, A.

AU - Perin, S.

AU - Forni, C.

AU - Fabbri, N.

AU - Salduca, N.

AU - Versari, M.

AU - Smith, K. V J

PY - 2001

Y1 - 2001

N2 - 570 patients with osteosarcoma of the extremities were treated with five different protocols of neoadjuvant chemotherapy at Rizzoli Institute between 1983 and 1995. Surgery consisted of limb salvage in 83% rotation plasty in 5% and amputation in 12%. The 5-year event-free survival (EFS) was 60% which varied according to the protocol followed, ranging from 47.6% to 66.4%. 234 patients relapsed. The pattern of relapse was analysed. The mean relapse time was 23.8 months (range: 2-96). The first site of systemic relapse was the lung in 88% (32% of these had less than three pulmonary metastases and 68% three or more), bone in 9%, lung and bone in 2% and other sites in 3%. The relapse time and the number of pulmonary metastases were strictly correlated with the efficacy of the protocol of chemotherapy used. Patients treated with the three protocols that gave a 5-year EFS of more than 60% relapsed later and had fewer pulmonary lesions than patients treated with the two protocols that gave a 5-year EFS of 47.6% and 52.5%. The rate of local recurrence was relatively low (6%). This was not correlated with the protocol or the type of surgery used: limb salvage (6.4%), rotation plasty or amputation (4.1%). However, the rate of local recurrence was very high (21.9%) in the few patients (7%) that had less than wide surgical margins. We conclude that for patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy: (a) the pattern of systemic relapse changes according to the efficacy of the protocol of chemotherapy used. This should be always considered when evaluating the preliminary results of new studies as well as in defining the time of follow-up; (b) limb salvage procedures are safe and do not jeopardise the outcome of the patient, provided that wide surgical margins are achieved.

AB - 570 patients with osteosarcoma of the extremities were treated with five different protocols of neoadjuvant chemotherapy at Rizzoli Institute between 1983 and 1995. Surgery consisted of limb salvage in 83% rotation plasty in 5% and amputation in 12%. The 5-year event-free survival (EFS) was 60% which varied according to the protocol followed, ranging from 47.6% to 66.4%. 234 patients relapsed. The pattern of relapse was analysed. The mean relapse time was 23.8 months (range: 2-96). The first site of systemic relapse was the lung in 88% (32% of these had less than three pulmonary metastases and 68% three or more), bone in 9%, lung and bone in 2% and other sites in 3%. The relapse time and the number of pulmonary metastases were strictly correlated with the efficacy of the protocol of chemotherapy used. Patients treated with the three protocols that gave a 5-year EFS of more than 60% relapsed later and had fewer pulmonary lesions than patients treated with the two protocols that gave a 5-year EFS of 47.6% and 52.5%. The rate of local recurrence was relatively low (6%). This was not correlated with the protocol or the type of surgery used: limb salvage (6.4%), rotation plasty or amputation (4.1%). However, the rate of local recurrence was very high (21.9%) in the few patients (7%) that had less than wide surgical margins. We conclude that for patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy: (a) the pattern of systemic relapse changes according to the efficacy of the protocol of chemotherapy used. This should be always considered when evaluating the preliminary results of new studies as well as in defining the time of follow-up; (b) limb salvage procedures are safe and do not jeopardise the outcome of the patient, provided that wide surgical margins are achieved.

KW - Chemotherapy

KW - Osteosarcoma

KW - Systemic relapse

UR - http://www.scopus.com/inward/record.url?scp=0035144560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035144560&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(00)00361-0

DO - 10.1016/S0959-8049(00)00361-0

M3 - Article

C2 - 11165127

AN - SCOPUS:0035144560

VL - 37

SP - 32

EP - 38

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 1

ER -